Renaissance Technologies
SPPI

Renaissance Technologies’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Renaissance Technologies’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,417,567
Closed -$1.36M – 4296
2023
Q2 		$1.36M Buy
1,417,567
+450,167
+47% +$445K ﹤0.01% 2257
2023
Q1 		$726K Sell
967,400
-99,000
-9% -$72.2K ﹤0.01% 2673
2022
Q4 		$393K Buy
1,066,400
+69,000
+7% +$29.1K ﹤0.01% 3096
2022
Q3 		$429K Sell
997,400
-193,649
-16% -$190K ﹤0.01% 3019
2022
Q2 		$929K Sell
1,191,049
-212,990
-15% -$188K ﹤0.01% 2772
2022
Q1 		$1.81M Buy
1,404,039
+573,790
+69% +$528K ﹤0.01% 2301
2021
Q4 		$1.05M Buy
830,249
+804,312
+3,101% +$1.44M ﹤0.01% 2600
2021
Q3 		$57K Sell
25,937
-205,230
-89% -$561K ﹤0.01% 3367
2021
Q2 		$867K Sell
231,167
-1,425,973
-86% -$4.96M ﹤0.01% 2733
2021
Q1 		$5.4M Sell
1,657,140
-720,662
-30% -$2.58M 0.01% 1609
2020
Q4 		$8.11M Sell
2,377,802
-994,813
-29% -$4.09M 0.01% 1303
2020
Q3 		$13.8M Buy
3,372,615
+370,542
+12% +$1.41M 0.01% 942
2020
Q2 		$10.1M Buy
3,002,073
+744,331
+33% +$2.17M 0.01% 1214
2020
Q1 		$5.26M Sell
2,257,742
-545,558
-19% -$1.49M 0.01% 1534
2019
Q4 		$10.2M Buy
2,803,300
+38,283
+1% +$309K 0.01% 1431
2019
Q3 		$22.9M Buy
2,765,017
+38,700
+1% +$313K 0.02% 886
2019
Q2 		$23.5M Buy
2,726,317
+1,034,135
+61% +$9.25M 0.02% 877
2019
Q1 		$18.1M Buy
1,692,182
+692,582
+69% +$7.42M 0.02% 1031
2018
Q4 		$8.75M Sell
999,600
-649,100
-39% -$8.27M 0.01% 1386
2018
Q3 		$27.7M Sell
1,648,700
-1,868,700
-53% -$40.4M 0.03% 728
2018
Q2 		$73.7M Sell
3,517,400
-2,062,600
-37% -$38.2M 0.08% 289
2018
Q1 		$89.8M Sell
5,580,000
-600,917
-10% -$11.9M 0.1% 233
2017
Q4 		$117M Sell
6,180,917
-478,400
-7% -$8.67M 0.13% 158
2017
Q3 		$93.7M Buy
6,659,317
+587,500
+10% +$5.32M 0.11% 207
2017
Q2 		$45.2M Buy
6,071,817
+392,017
+7% +$2.56M 0.06% 417
2017
Q1 		$36.9M Buy
5,679,800
+502,488
+10% +$2.81M 0.05% 475
2016
Q4 		$22.9M Sell
5,177,312
-364,645
-7% -$1.53M 0.04% 698
2016
Q3 		$25.9M Buy
5,541,957
+983,840
+22% +$5.83M 0.05% 562
2016
Q2 		$29.9M Buy
4,558,117
+1,254,017
+38% +$8.86M 0.06% 456
2016
Q1 		$21M Buy
3,304,100
+712,781
+28% +$3.66M 0.04% 621
2015
Q4 		$15.6M Buy
2,591,319
+817,802
+46% +$4.68M 0.03% 687
2015
Q3 		$10.6M Sell
1,773,517
-12,400
-0.7% -$86.1K 0.03% 905
2015
Q2 		$12.2M Buy
1,785,917
+394,700
+28% +$2.51M 0.03% 822
2015
Q1 		$8.45M Buy
1,391,217
+1,143,217
+461% +$7.61M 0.02% 1037
2014
Q4 		$1.72M Buy
+248,000
New +$1.82M ﹤0.01% 1885
2014
Q3 		– Sell
-185,917
Closed -$1.51M – 2997
2014
Q2 		$1.51M Buy
185,917
+14,610
+9% +$111K ﹤0.01% 1871
2014
Q1 		$1.34M Buy
171,307
+101,790
+146% +$861K ﹤0.01% 1947
2013
Q4 		$615K Buy
69,517
+57,500
+478% +$514K ﹤0.01% 2286
2013
Q3 		$101K Buy
+12,017
New +$97.3K ﹤0.01% 2685

Renaissance Technologies's SPPI Position: Q3 2023 in Review

Renaissance Technologies sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 1,417,567 shares — an estimated $1.36M sold.

Renaissance Technologies first reported a position in SPPI in Q3 2013 and held it in 39 quarters. The position peaked at $117M in Q4 2017. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.

  • Renaissance Technologies reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
  • Renaissance Technologies sold 1,417,567 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $1.36M.
  • Renaissance Technologies first reported a position in Spectrum Pharmaceuticals Inc in Q3 2013 and held it in 39 quarters.
  • Renaissance Technologies's Spectrum Pharmaceuticals Inc position peaked at $117M in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.

Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.